
Dover (DOV) Stock Forecast & Price Target
Dover (DOV) Analyst Ratings
Bulls say
Dover's positive outlook is supported by its recent booking growth, which increased by 8% in the third quarter of 2025, primarily driven by robust performance in biopharma and clean energy technologies. Furthermore, the company's adjusted segment EBITDA margins have expanded significantly by 480 basis points from 2018 to 2024, reflecting a strategic shift towards less cyclical products and a higher mix of Pumps & Process and Clean Energy segments. Additionally, Dover has raised its total revenue growth guidance to a midpoint range of 4%-6%, factoring in favorable foreign exchange impacts and acquisitions, indicating strong momentum for future performance.
Bears say
Dover is experiencing challenges in its operational effectiveness, as indicated by a total book-to-bill ratio of 0.98x, which fell below expectations and demonstrates a concerning trend in new orders compared to shipments. Additionally, the company's organic sales from several segments, including Clean Energy and Engineered Products, recorded declines of -5.1% and -7.0% respectively, suggesting weaknesses in market demand and execution. Further complicating matters, Dover's stock trades at a significant discount to peers, with a price-to-earnings ratio of 17.9x projected earnings, positioning the company at the lower end of its relative P/E range and reflecting investor skepticism regarding future performance and the risks associated with recent acquisitions.
This aggregate rating is based on analysts' research of Dover and is not a guaranteed prediction by Public.com or investment advice.
Dover (DOV) Analyst Forecast & Price Prediction
Start investing in Dover (DOV)
Order type
Buy in
Order amount
Est. shares
0 shares